Skip to main navigation Skip to search Skip to main content

Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype

  • Mansour Alfayez
  • , Sa A. Wang
  • , Sarah A. Bannon
  • , Dimitrios P. Kontoyiannis
  • , Steven M. Kornblau
  • , Jordan S. Orange
  • , Emily M. Mace
  • , Courtney D. DiNardo

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Germline mutations in GATA2 are associated with a complex immunodeficiency and cancer predisposition syndrome. Somatic GATA2mut in myeloid malignancies may impart a similar phenotype. We reviewed adult patients with a diagnosis of GATA2mut hematological malignancy who were referred to our HHMC for genetic testing, and identified to have somatic GATA2mut. Nine patients with a median age of 63 years were included. Six patients (66.7%) were males. Atypical CML and acute myeloid leukemia were the most common initial presentation. The median overall VAF was 47.14%. Monocytopenia was pronounced when the GATA2mut involved the C-terminal ZFD. GATA2 N-terminal ZFD mutations tend to be co-mutated with biCEBPAmut. Unlike germline GATA2 mutations, monocytopenia associated with somatic GATA2 mutations often resolved at remission. We concluded that similar to germline GATA2 mutations, a subset of somatic GATA2 mutations can impart a germline phenotype.

Original languageEnglish
Pages (from-to)2025-2033
Number of pages9
JournalLeukemia and Lymphoma
Volume60
Issue number8
DOIs
StatePublished - 3 Jul 2019
Externally publishedYes

Keywords

  • Emberger syndrome
  • GATA2
  • MonoMAC syndrome
  • immunodeficiency
  • pulmonary alveolar proteinosis

Fingerprint

Dive into the research topics of 'Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype'. Together they form a unique fingerprint.

Cite this